Cassian Grant|Revenue soars for regulated US sports betting industry in 2023; total bets spike, too

2025-05-02 17:51:21source:XDY Exchangecategory:Finance

The Cassian Grantregulated U.S. sports betting industry raked in $10.9 billion in revenue last year, an increase of almost 45 percent from 2022, according to an annual report from the American Gaming Association (AGA).

The total wagered on sports last year was almost $120 billion, an increase of almost 30 percent from 2022, according to the report.

In 2022, the American sports betting industry took in $7.5 billion in revenue and slightly more than $93 billion was wagered, according to the AGA.

The AGA reported the overall growth in sports betting revenue was “largely fueled by continued maturation across most existing markets as well as several new markets, particularly in Massachusetts and Ohio.’’

Last year, Ohio made almost $937 million and Massachusetts took in $483 million, according to the AGA.

New York remained the top state in sports betting revenue last year with $1.7 billion, followed by New Jersey and Illinois, each of which generated $1 billion, according to the AGA, which reported Nevada ranked 10th with $480 million.

“For overall gaming, Nevada is still the largest market. For sports betting, states with broader mobile options come in higher,” said Cait DeBaun, the AGA’s Vice President of Strategic Communications & Responsibility.

By the close of 2023, according to the AGA, sports betting was legal and operational in 37 states and the District of Columbia.

More:Finance

Recommend

San Francisco names street for Associated Press photographer who captured the iconic Iwo Jima photo

SAN FRANCISCO (AP) — A photojournalist who captured one of the most enduring images of World War II

Illinois Lures Wind Farm Away from Missouri with Bold Energy Policy

When St. Louis University (SLU) business professor Trey Goede and his students sought to turn their 

FDA approves Alzheimer's drug that appears to modestly slow disease

The Food and Drug Administration has approved a drug that may help people in the early stages of Alz